Tianyin Pharmaceutical Co Stock Current Asset
Tianyin Pharmaceutical Co fundamentals help investors to digest information that contributes to Tianyin Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Tianyin Stock. The fundamental analysis module provides a way to measure Tianyin Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tianyin Pharmaceutical stock.
Tianyin |
Tianyin Pharmaceutical Co Company Current Asset Analysis
Tianyin Pharmaceutical's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Tianyin Pharmaceutical Current Asset | 27.53 M |
Most of Tianyin Pharmaceutical's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tianyin Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
CompetitionIn accordance with the recently published financial statements, Tianyin Pharmaceutical Co has a Current Asset of 27.53 M. This is much higher than that of the sector and significantly higher than that of the Pharmaceutical Products industry. The current asset for all United States stocks is notably lower than that of the firm.
Tianyin Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tianyin Pharmaceutical's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tianyin Pharmaceutical could also be used in its relative valuation, which is a method of valuing Tianyin Pharmaceutical by comparing valuation metrics of similar companies.Tianyin Pharmaceutical is currently under evaluation in current asset category among its peers.
Tianyin Fundamentals
| Return On Asset | -1.24 | |||
| Profit Margin | (13.72) % | |||
| Operating Margin | (7.06) % | |||
| Current Valuation | (7.22 M) | |||
| Shares Outstanding | 29.43 M | |||
| Shares Owned By Insiders | 26.44 % | |||
| Shares Owned By Institutions | 6.40 % | |||
| Number Of Shares Shorted | 112.52 K | |||
| Price To Earning | 3.34 X | |||
| Price To Book | 0.05 X | |||
| Price To Sales | 0.17 X | |||
| Revenue | 29.64 M | |||
| Gross Profit | 15.88 M | |||
| Net Income | (4.07 M) | |||
| Cash And Equivalents | 15.16 M | |||
| Cash Per Share | 0.52 X | |||
| Total Debt | 2.94 M | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 6.64 X | |||
| Cash Flow From Operations | (1.25 M) | |||
| Earnings Per Share | (0.14) X | |||
| Number Of Employees | 1 K | |||
| Beta | 2.79 | |||
| Total Asset | 101.35 M | |||
| Retained Earnings | 50.19 M | |||
| Working Capital | 23.39 M | |||
| Current Asset | 27.53 M | |||
| Current Liabilities | 4.15 M |
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in Tianyin Stock
If you are still planning to invest in Tianyin Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tianyin Pharmaceutical's history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |